Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HER1 Antagonists [MoA]

Known as: Epidermal Growth Factor Receptor Inhibitors, HER1 Antagonists, HER-1 Inhibitors 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
  • R. Ali, M. Wendt
  • Signal Transduction and Targeted Therapy
  • 2017
  • Corpus ID: 18333600
The epidermal growth factor receptor (EGFR) is one of the most well-studied signaling pathways in cancer progression. As a result… Expand
  • figure 1
  • figure 2
2015
2015
Resistance to the EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib, often related to Ras or secondary EGFR… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 3
  • figure 4
Highly Cited
2013
Highly Cited
2013
Epidermal EGFR regulates skin inflammation and contributes to skin barrier function and host defense. Skin-Deep Search for the… Expand
Review
2013
Review
2013
  • R. Bodnar
  • Advances in wound care
  • 2013
  • Corpus ID: 36943220
SIGNIFICANCE Epidermal growth factor (EGF) and EGF receptor (EGFR) play an essential role in wound healing through stimulating… Expand
Highly Cited
2011
Highly Cited
2011
Purpose: Diverse immune-related effects occur with the use of epidermal growth factor receptor inhibitors (EGFRI). In addition to… Expand
  • table 1
Highly Cited
2010
Highly Cited
2010
INTRODUCTION EGFR inhibitors (EGFRIs) have been shown to be clinically effective in various cancers. Unique skin toxicity is… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2009
Highly Cited
2009
The epidermal growth factor receptor (egfr) is often overexpressed or dysregulated in a variety of solid tumours, including… Expand
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Highly Cited
2009
Highly Cited
2009
Background  Acute and subacute cutaneous side‐effects of epidermal growth factor receptor inhibitors (EGFRIs) are very frequent… Expand
Highly Cited
2008
Highly Cited
2008
A major question regarding the sensitivity of solid tumors to targeted kinase inhibitors is why some tumors respond and others do… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Review
2007
Review
2007
Epidermal growth factor receptor inhibitors (EGFRIs) have demonstrated improved overall survival in patients with non-small cell… Expand